Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury ST. GALLEN, Switzerland & UNIONDALE, N.Y. — (BUSINESS WIRE) — Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/…